Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234387 | SCV000285330 | benign | Tuberous sclerosis 2 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705242 | SCV000515036 | likely benign | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571675 | SCV000664681 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000234387 | SCV002039283 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000571675 | SCV002533363 | benign | Hereditary cancer-predisposing syndrome | 2020-10-28 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002494628 | SCV002809675 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-05-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001705242 | SCV005216993 | likely benign | not provided | criteria provided, single submitter | not provided | ||
KCCC/NGS Laboratory, |
RCV000234387 | SCV005881415 | benign | Tuberous sclerosis 2 | 2025-02-01 | criteria provided, single submitter | clinical testing |